Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Invitrogen™ Nipocalimab Recombinant Monoclonal Antibody 

Invitrogen™ Nipocalimab Recombinant Monoclonal Antibody

Catalog No. MA559522
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
100 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MA559522 1 mg
MA559521 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. MA559522 Supplier Invitrogen™ Supplier No. MA559522
Add to Cart
Edge
Add to Cart

Description

Recombinant Monoclonal Antibody

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.

Nipocalimab works by binding to the neonatal Fc receptor (FcRn), inhibiting its interaction with immunoglobulin G (IgG), thereby reducing the levels of pathogenic IgG antibodies.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Nipocalimab
Applications ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Classification Recombinant Monoclonal
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation 25mM histidine with 0.01% Tween 80, 8% sucrose and no preservative; pH 6.2
Gene Alias JNJ 80202135; M 281
Host Species Human
Purification Method Protein A
Quantity 1 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Lyophilized
Isotype IgG1 λ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.